Archived:Clear cell renal cell carcinoma: Difference between revisions
| [unchecked revision] | [unchecked revision] |
| Line 26: | Line 26: | ||
== Genomic Gain/Loss/LOH == | == Genomic Gain/Loss/LOH == | ||
chr1 Loss: 1p | |||
chr2 | |||
chr3 Loss: 3p (3p21, 3p25 and/or 3p13-p14) | |||
chr4 Loss: 4q | |||
chr5 Gain: 5q | |||
chr6 | |||
chr7 | |||
chr8 Loss: 8p | |||
chr9 Loss: 9p, 9q | |||
chr10 | |||
chr11 | |||
chr12 | |||
chr13 | |||
chr14 Loss: 14q | |||
chr15 | |||
chr16 | |||
chr17 | |||
chr18 | |||
chr19 | |||
chr20 | |||
chr21 | |||
chr22 | |||
X | |||
Y | |||
== Rearrangements == | == Rearrangements == | ||